Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 1124-1127

  Lee, Yi Tzu ^a,b,c   Kuo, Shu Chen ^a,d   Chiang, Mei Chun ^c   Yang, Su Pen ^a,c   Chen, Chien Pei ^c   Chen, Te Li ^a,c   Fung, Chang Phone ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Chutung Veterans Hospital   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ARGININE; AZTREONAM; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CLAVULANIC ACID; GLYCINE; IRON CHELATING AGENT; LEUCINE; LIPOPOLYSACCHARIDE; PENICILLIN G; PIPERACILLIN; TAZOBACTAM; TICARCILLIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; ENZYME ACTIVITY; ESCHERICHIA COLI; GENOTYPE; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PLASMIDS; SEQUENCE ANALYSIS, DNA; TAIWAN; YOUNG ADULT;

EID: 84862908892     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00622-11     Document Type: Article

References (17)

1. Chen TL, et al. 2010. Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to β-lactam resistance in Acinetobacter genomic species 13TU. Antimicrob. Agents Chemother. 54:3107-3112.
2. OXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob. Agents Chemother. 54:4575-4581.
3. Chen TL, et al. 2007. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin. Microbiol. Infect. 13:801-806.
4. OXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob. Agents Chemother. 52:2573-2580.
5. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034.
7. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951. (Pubitemid 350131182)
8. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. 2009. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:5035-5038.
9. Hu WS, et al. 2007. An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3844-3852. (Pubitemid 350057780)
10. Huang LY, et al. 2008. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin. Microbiol. Infect. 14:1010-1019.
11. Lee YT, et al. 2009. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int. J. Antimicrob. Agents 34:580-584.
12. OXA-51-like in non-baumannii Acinetobacter spp. J. Chemother. 21:514-520.
13. Nemec A, et al. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162:393-404.
14. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
15. Poirel L, Guibert M, Bellais S, Naas T, Nordmann P. 1999. Integronand carbenicillinase-mediated reduced susceptibility to amoxicillinclavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 from French patients. Antimicrob. Agents Chemother. 43:1098-1104. (Pubitemid 29214731)
16. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836. (Pubitemid 44151282)
17. OXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976.